Light to moderate but sustained weight loss through diet and exercise might support glycemic control in people who have type 2 diabetes, according to a 2023 study
HyQvias label expansion is based on data from the randomized, placebo-controlled ADVANCE-CIDP 1 trial and single-arm open-label extension ADVANCE-CIDP 3 trial, each of which revealed a favorable safety profile for the treatment
Today peptides, tomorrow homeopathy (...though at least for the latter, a presumption of safety would have a more rational basis) Instead of focusing on banning things a small subset of people are using and seeing benefit in, can we focus on modernizing the clinical trial system to promote efficient drug development
Whilst these are both obesity-related cancer types, this study did not report the incidence of obesity in its participants, which makes it difficult to conclude how much this effect is due to weight loss
Furthermore, when food intake is restricted, careful monitoring or dose adjustments may be necessary during colonoscopy prep
For example, people with autoimmune diseases might have a higher risk of drug allergies